Name : HCF2 Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN5922084401
| Long name | HCF2 Primary Polyclonal Antibody |
| Also known as | HCF2 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | HCF2 |
| Specificity | This is a highly specific antibody against HCF2 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human HCF2/Heparin Cofactor II |
| Gene ID number | 3053 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | Also inhibits chymotrypsin, Defects in SERPIND1 are the cause of Heparin Cofactor II deficiency, Heparin Cofactor II becomes the predominant thrombin inhibitor in place of antithrombin III (AT III), Heparin Cofactor II deficiency is an important risk factor for hereditary thrombophilia, Heparin Cofactor II deficiency is inherited as an autosomal dominant disorder, Heparin Cofactor II is antigenically distinct from AT III, Heparin Cofactor II is normal in patients with AT III deficiency and is low in patients with disseminated intravascular coagulation, In the presence of the latter, It is expressed predominantly in liver, Its function is: thrombin inhibitor activated by the glycosaminoglycans, The N terminal acidic repeat region mediates, The first of these to be well characterized was antithrombin III, a multifactorial trait characterized by recurrent thrombosis and abnormal platelet aggregation in response to various agents, a viral transcription factor that activates the viral immediate-early (IE) genes, but in a glycosaminoglycan independent manner and peptides at the N terminal of Heparin Cofactor II have chemotactic activity for both monocytes and neutrophils, heparin or dermatan sulfate, in part, in which affected individuals are prone to develop serious spontaneous thrombosis, the glycosaminoglycan accelerated thrombin inhibition, The anticoagulant action of heparin is dependent on plasma components termed heparin cofactors, The herpes simplex virus (HSV) infection is initiated by VP16 |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | HCF2, HEP2_HUMAN, HLS2, LS2, Leuserpin 2, Protease inhibitor leuserpin 2, SERPIND1, HC II |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | HCF2 |
| Short name | HCF2 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | HCF2 (Antibody to) |
| Alternative technique | antibodies |
| Identity | 4838 |
| Gene | SERPIND1 |
| Long gene name | serpin family D member 1 |
| Synonyms gene | HCF2 |
| Synonyms gene name | clade D (heparin cofactor), clade D (heparin cofactor), member 1 , member 1 serpin peptidase inhibitor, serine (or cysteine) proteinase inhibitor |
| Synonyms | HC-II HLS2 HC2 D22S673 |
| Synonyms name | heparin cofactor II heparin cofactor 2 |
| Locus | 22q11, 21 |
| Discovery year | 1988-05-31 |
| GenBank acession | M12849 |
| Entrez gene record | 3053 |
| Pubmed identfication | 1671335 24172014 |
| RefSeq identity | NM_000185 |
| Classification | Serpin peptidase inhibitors |
| Havana BLAST/BLAT | OTTHUMG00000150755 |
| Locus Specific Databases | LRG_594 |